Your SlideShare is downloading. ×
Paralysis Global Clinical Trials Review, H1, 2014
Paralysis Global Clinical Trials Review, H1, 2014
Summary
GlobalData's c...
reneuron Group Plc 35
clinical Trial Overview Of Reneuron Group Plc 35
macrogenics, Inc. 36
clinical Trial Overview Of Mac...
paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Stemedica Cell Technologies, Inc., 2014* 32
para...
Upcoming SlideShare
Loading in...5
×

Research on Paralysis Global Clinical Trials Review, H1, 2014

92

Published on

Paralysis Global Clinical Trials Review, H1, 2014 @ http://www.researchmoz.us/paralysis-global-clinical-trials-review-h1-2014-report.html

This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
92
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Research on Paralysis Global Clinical Trials Review, H1, 2014"

  1. 1. Paralysis Global Clinical Trials Review, H1, 2014 Paralysis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Paralysis Global Clinical Trials Review, H1, 2014" provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Paralysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 paralysis 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Five Countries Contributing To Clinical Trials In Middle East And Africa 13 top Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Paralysis To Central Nervous System Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Paralysis To Central Nervous System Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Paralysis 25 subjects Recruited Over A Period Of Time 27 clinical Trials By Sponsor Type 28 prominent Sponsors 29 top Companies Participating In Paralysis Therapeutics Clinical Trials 30 prominent Drugs 31 clinical Trial Profiles 32 clinical Trial Overview Of Top Companies 32 stemedica Cell Technologies, Inc. 32 clinical Trial Overview Of Stemedica Cell Technologies, Inc. 32 teva Pharmaceutical Industries Limited 33 clinical Trial Overview Of Teva Pharmaceutical Industries Limited 33 teijin Limited 34 clinical Trial Overview Of Teijin Limited 34 Paralysis Global Clinical Trials Review, H1, 2014
  2. 2. reneuron Group Plc 35 clinical Trial Overview Of Reneuron Group Plc 35 macrogenics, Inc. 36 clinical Trial Overview Of Macrogenics, Inc. 36 emergent Biosolutions Inc. 37 clinical Trial Overview Of Emergent Biosolutions Inc. 37 bayer Ag 38 clinical Trial Overview Of Bayer Ag 38 asahi Kasei Corporation 39 clinical Trial Overview Of Asahi Kasei Corporation 39 clinical Trial Overview Of Top Institutes / Government 40 national Institute Of Neurological Disorders And Stroke 40 clinical Trial Overview Of National Institute Of Neurological Disorders And Stroke 40 u.s. Department Of Veterans Affairs 41 clinical Trial Overview Of U.s. Department Of Veterans Affairs 41 assistance Publique - Hopitaux De Paris 42 clinical Trial Overview Of Assistance Publique - Hopitaux De Paris 42 university Of Miami 43 clinical Trial Overview Of University Of Miami 43 university Of Florida 44 clinical Trial Overview Of University Of Florida 44 national Cancer Institute 45 clinical Trial Overview Of National Cancer Institute 45 hadassah Medical Organization 46 clinical Trial Overview Of Hadassah Medical Organization 46 medical University Of Vienna 47 clinical Trial Overview Of Medical University Of Vienna 47 rouen University Hospital 48 clinical Trial Overview Of Rouen University Hospital 48 imperial College London 49 clinical Trial Overview Of Imperial College London 49 five Key Clinical Profiles 50 appendix 74 abbreviations 74 definitions 74 research Methodology 75 secondary Research 75 about Globaldata 76 contact Us 76 disclaimer 76 source 76 list Of Tables paralysis Therapeutics, Global, Clinical Trials By Region, 2014* 7 paralysis Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 paralysis Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 paralysis Therapeutics Clinical Trials, Asia-pacific, Top Five Countries, 2014* 10 paralysis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 paralysis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 paralysis Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries, 2014* 13 paralysis Therapeutics Clinical Trials, Central And South America, Top Countries, 2014* 14 proportion Of Paralysis To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 paralysis Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 paralysis Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Paralysis To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 paralysis Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 paralysis Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 paralysis Therapeutics, Global, Clinical Trials By Phase, 2014* 21 paralysis Therapeutics, Global, Clinical Trials In Progress By Phase 2014* 22 paralysis Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 paralysis Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 paralysis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25 paralysis Therapeutics, Global, Terminated Clinical Trials, 2014* 26 paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27 paralysis Therapeutics Market, Global, Clinical Trials By Sponsor Type, 2014* 28 paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29 paralysis Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 30 paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 31 Paralysis Global Clinical Trials Review, H1, 2014
  3. 3. paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Stemedica Cell Technologies, Inc., 2014* 32 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Teva Pharmaceutical Industries Limited, 2014* 33 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Teijin Limited, 2014* 34 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Reneuron Group Plc, 2014* 35 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Macrogenics, Inc., 2014* 36 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Emergent Biosolutions Inc., 2014* 37 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Bayer Ag, 2014* 38 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Asahi Kasei Corporation, 2014* 39 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By National Institute Of Neurological Disorders And Stroke, 2014* 40 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By U.s. Department Of Veterans Affairs, 2014* 41 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Assistance Publique - Hopitaux De Paris, 2014* 42 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Miami, 2014* 43 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Florida, 2014* 44 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By National Cancer Institute, 2014* 45 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Hadassah Medical Organization, 2014* 46 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Medical University Of Vienna, 2014* 47 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Rouen University Hospital, 2014* 48 paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials By Imperial College London, 2014* 49 list Of Figures paralysis Therapeutics, Global, Clinical Trials By Region (%), 2014* 7 paralysis Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 paralysis Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 paralysis Therapeutics Clinical Trials, Asia-pacific, Top Five Countries (%), 2014* 10 paralysis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 paralysis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 paralysis Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries (%), 2014* 13 paralysis Therapeutics Clinical Trials, Central And South America, Top Countries (%), 2014* 14 proportion Of Paralysis To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 paralysis Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 paralysis Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Paralysis To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 paralysis Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 paralysis Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 paralysis Therapeutics, Global, Clinical Trials By Phase (%), 2014* 21 paralysis Therapeutics, Global, Clinical Trials In Progress By Phase, 2014* 22 paralysis Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 paralysis Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27 paralysis Therapeutics Market, Global, Clinical Trials By Sponsor Type (%), 2014* 28 paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29 paralysis Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 30 paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 31 globaldata Methodology 75 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Paralysis Global Clinical Trials Review, H1, 2014

×